• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过尿频-尿急综合征女性患者的尿生物标志物鉴别不同的膀胱及膀胱出口功能障碍

Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.

作者信息

Jhang Jia-Fong, Jiang Yuan-Hong, Kuo Hann-Chorng

机构信息

Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan.

出版信息

Biomedicines. 2023 Feb 23;11(3):673. doi: 10.3390/biomedicines11030673.

DOI:10.3390/biomedicines11030673
PMID:36979652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045187/
Abstract

OBJECTIVES

To investigate the role of urinary biomarkers in discriminating different bladder and bladder outlet dysfunctions in women with frequency-urgency syndrome.

MATERIALS AND METHODS

Urine samples collected from 146 women with frequency-urgency syndrome and 34 controls were investigated. All patients were included in previous clinical trials of functional urology studies and underwent a videourodynamic study. Patients with frequency-urgency syndrome were subdivided into idiopathic detrusor overactivity (IDO), neurogenic detrusor overactivity (NDO), dysfunctional voiding (DV), and hypersensitive bladder (HSB) subgroups. Urine samples were collected before any treatment, and urinary inflammatory proteins (interleukin- (IL-) 1β, IL-2, IL-6, IL-8, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor (VEGF)), neurogenic proteins (nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and prostaglandin E2 (PGE2)), and oxidative stress biomarkers (8-isoprostane, total antioxidant capacity (TAC), and 8-hydroxydeoxyguanosine (8-OHdG)) were measured and compared between the different OAB subgroups and controls.

RESULTS

Of the 146 patients, 31 had IDO, 41 had NDO, 45 had DV, and 29 had HSB. The control group included 34 women. The patients with HSB had lower urinary TAC and IL-2 levels than the controls. The patients with IDO, NDO, and DV had significantly higher urinary TNF-α levels than those with HSB. The patients with IDO and NDO showed an increase in the urinary 8-isoprostane levels, whereas the patients with IDO had higher urinary IL-2, NGF, and BDNF levels than those with NDO. The other urinary inflammatory biomarkers did not show enough significant differences to discriminate between the different bladder and bladder outlet dysfunctions.

CONCLUSIONS

The urinary levels of inflammatory, neurogenic, and oxidative stress biomarkers varied widely among the patients with bladder and bladder outlet dysfunction. This study's results provide evidence that women with frequency-urgency syndrome and different urodynamic subtypes have varying bladder inflammation and oxidative stress conditions, which might have an impact on treatment outcomes.

摘要

目的

探讨尿生物标志物在鉴别尿频尿急综合征女性不同膀胱及膀胱出口功能障碍中的作用。

材料与方法

对146例尿频尿急综合征女性患者和34例对照者的尿液样本进行研究。所有患者均纳入既往功能性泌尿学研究的临床试验,并接受了视频尿动力学检查。尿频尿急综合征患者被分为特发性逼尿肌过度活动(IDO)、神经源性逼尿肌过度活动(NDO)、排尿功能障碍(DV)和膀胱过敏(HSB)亚组。在任何治疗前采集尿液样本,检测并比较不同膀胱过度活动症(OAB)亚组和对照者的尿炎症蛋白(白细胞介素-(IL-)1β、IL-2、IL-6、IL-8、肿瘤坏死因子-α(TNF-α)和血管内皮生长因子(VEGF))、神经源性蛋白(神经生长因子(NGF)、脑源性神经营养因子(BDNF)和前列腺素E2(PGE2))以及氧化应激生物标志物(8-异前列腺素、总抗氧化能力(TAC)和8-羟基脱氧鸟苷(8-OHdG))。

结果

146例患者中,31例患有IDO,41例患有NDO,45例患有DV,29例患有HSB。对照组包括34名女性。HSB患者的尿TAC和IL-2水平低于对照组。IDO、NDO和DV患者的尿TNF-α水平显著高于HSB患者。IDO和NDO患者的尿8-异前列腺素水平升高,而IDO患者的尿IL-2、NGF和BDNF水平高于NDO患者。其他尿炎症生物标志物未显示出足够显著的差异来区分不同的膀胱及膀胱出口功能障碍。

结论

膀胱及膀胱出口功能障碍患者的尿炎症、神经源性和氧化应激生物标志物水平差异很大。本研究结果提供了证据,表明尿频尿急综合征及不同尿动力学亚型的女性存在不同的膀胱炎症和氧化应激状况,这可能会影响治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e932/10045187/0619b9b8159b/biomedicines-11-00673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e932/10045187/0619b9b8159b/biomedicines-11-00673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e932/10045187/0619b9b8159b/biomedicines-11-00673-g001.jpg

相似文献

1
Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.通过尿频-尿急综合征女性患者的尿生物标志物鉴别不同的膀胱及膀胱出口功能障碍
Biomedicines. 2023 Feb 23;11(3):673. doi: 10.3390/biomedicines11030673.
2
Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.尿氧化应激生物标志物水平可能有助于识别患有尿频尿急综合征的女性的功能性膀胱疾病。
J Clin Med. 2023 Mar 17;12(6):2336. doi: 10.3390/jcm12062336.
3
Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.尿液生物标志物可能是下尿路功能障碍鉴别诊断的一种有用工具。
Tzu Chi Med J. 2023 Dec 13;36(2):110-119. doi: 10.4103/tcmj.tcmj_221_23. eCollection 2024 Apr-Jun.
4
Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.尿生物标志物在鉴别间质性膀胱炎/膀胱疼痛综合征与男性下尿路功能障碍中的应用
Int J Mol Sci. 2023 Jul 27;24(15):12055. doi: 10.3390/ijms241512055.
5
A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.特发性逼尿肌过度活动症患者与神经源性逼尿肌过度活动症患者对首次膀胱内注射A型肉毒杆菌毒素反应的比较。
J Urol. 2005 Sep;174(3):984-9. doi: 10.1097/01.ju.0000169480.43557.31.
6
Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study.尿生物标志物在鉴别伴有膀胱过度活动症的女性排尿功能障碍中的性能:一项前瞻性初步研究。
Int Urol Nephrol. 2022 Oct;54(10):2497-2502. doi: 10.1007/s11255-022-03265-7. Epub 2022 Jul 20.
7
Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.尿神经生长因子水平在逼尿肌过度活动患者中升高,而在对膀胱注射肉毒毒素 A 有反应的患者中降低。
Eur Urol. 2009 Oct;56(4):700-6. doi: 10.1016/j.eururo.2008.04.037. Epub 2008 Apr 30.
8
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
9
Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders.利用尿液生物标志物区分感觉性膀胱障碍女性的膀胱功能障碍。
Int J Mol Sci. 2024 Aug 29;25(17):9359. doi: 10.3390/ijms25179359.
10
Urodynamic findings in women with refractory overactive bladder symptoms.难治性膀胱过度活动症症状女性的尿动力学检查结果
Int J Urol. 2016 Jan;23(1):75-9. doi: 10.1111/iju.12954. Epub 2015 Sep 28.

引用本文的文献

1
A Dataset for Constructing the Network Pharmacology of Overactive Bladder and Its Application to Reveal the Potential Therapeutic Targets of Rhynchophylline.一种用于构建膀胱过度活动症网络药理学的数据集及其在揭示钩藤碱潜在治疗靶点中的应用
Pharmaceuticals (Basel). 2024 Sep 24;17(10):1253. doi: 10.3390/ph17101253.
2
The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018.膀胱过度活动症与全身免疫炎症指数的关系:NHANES 2005 至 2018 年的横断面研究。
Sci Rep. 2024 May 31;14(1):12579. doi: 10.1038/s41598-024-63448-3.
3
Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.

本文引用的文献

1
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
2
Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.尿氧化应激生物标志物作为间质性膀胱炎/膀胱疼痛综合征的新型生物标志物
Biomedicines. 2022 Jul 14;10(7):1701. doi: 10.3390/biomedicines10071701.
3
Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study.
尿液生物标志物可能是下尿路功能障碍鉴别诊断的一种有用工具。
Tzu Chi Med J. 2023 Dec 13;36(2):110-119. doi: 10.4103/tcmj.tcmj_221_23. eCollection 2024 Apr-Jun.
尿生物标志物在鉴别伴有膀胱过度活动症的女性排尿功能障碍中的性能:一项前瞻性初步研究。
Int Urol Nephrol. 2022 Oct;54(10):2497-2502. doi: 10.1007/s11255-022-03265-7. Epub 2022 Jul 20.
4
Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.利用尿细胞因子和趋化因子水平来识别间质性膀胱炎/膀胱疼痛综合征患者的膀胱状况并预测治疗结果。
Biomedicines. 2022 May 17;10(5):1149. doi: 10.3390/biomedicines10051149.
5
Diagnostic and prognostic value of urine biomarkers among women with dysfunctional voiding.尿生物标志物在排尿功能障碍女性中的诊断和预后价值。
Sci Rep. 2022 Apr 22;12(1):6608. doi: 10.1038/s41598-022-10696-w.
6
How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies.如何为膀胱过度活动症选择合适的药物:来自米拉贝隆研究最大规模综合临床试验数据库分析的结果
Tzu Chi Med J. 2020 Sep 16;34(1):23-28. doi: 10.4103/tcmj.tcmj_167_20. eCollection 2022 Jan-Mar.
7
Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse.尿神经生长因子可能无法作为盆腔器官脱垂患者膀胱过度活动症的生物标志物。
J Clin Med. 2022 Feb 13;11(4):971. doi: 10.3390/jcm11040971.
8
The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis.在女性患者中使用尿生物标志物诊断膀胱过度活动症。系统评价和荟萃分析。
Int Urogynecol J. 2021 Dec;32(12):3143-3155. doi: 10.1007/s00192-021-04945-1. Epub 2021 Aug 7.
9
Diagnostic value of nerve growth factor in detrusor overactivity: a study on women with mixed urinary incontinence.神经生长因子在逼尿肌过度活动中的诊断价值:混合性尿失禁女性的研究。
Int Urol Nephrol. 2021 Aug;53(8):1557-1562. doi: 10.1007/s11255-021-02864-0. Epub 2021 Apr 17.
10
Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.ESSIC 2 型间质性膀胱炎/膀胱疼痛综合征和伴有新型诊断算法的过度活动膀胱中的尿生物标志物。
Sci Rep. 2021 Jan 13;11(1):914. doi: 10.1038/s41598-020-80131-5.